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ABSTRACT
Background and Objectives. White adipose tissue (WAT) shows marked sex- and
diet-dependent differences. However, our metabolic knowledge of WAT, especially on
amino acid metabolism, is considerably limited. In the present study, we compared
the influence of sex on the amino acid metabolism profile of the four main WAT sites,
focused on the paths related to ammonium handling and the urea cycle, as a way to
estimate the extent of WAT implication on body amino-nitrogen metabolism.
Experimental Design. Adult female and male rats were maintained, undisturbed,
under standard conditions for one month. After killing them under isoflurane
anesthesia. WAT sites were dissected and weighed. Subcutaneous, perigonadal,
retroperitoneal and mesenteric WAT were analyzed for amino acid metabolism gene
expression and enzyme activities.
Results. There was a considerable stability of the urea cycle activities and expressions,
irrespective of sex, and with only limited influence of site. Urea cycle was more
resilient to change than other site-specialized metabolic pathways. The control
of WAT urea cycle was probably related to the provision of arginine/citrulline, as
deduced from the enzyme activity profiles. These data support a generalized role
of WAT in overall amino-N handling. In contrast, sex markedly affected WAT
ammonium-centered amino acid metabolism in a site-related way, with relatively
higher emphasis in males’ subcutaneous WAT.
Conclusions. We found that WAT has an active amino acid metabolism. Its gene
expressions were lower than those of glucose-lipid interactions, but the differences
were quantitatively less important than usually reported. The effects of sex on
urea cycle enzymes expression and activity were limited, in contrast with the wider
variations observed in other metabolic pathways. The results agree with a centralized
control of urea cycle operation affecting the adipose organ as a whole.
Subjects Biochemistry, Nutrition, Metabolic Sciences
Keywords Adipose tissue, Urea cycle, Ammonium, Citrulline, Urea, Adipose organ, Lipogenesis
INTRODUCTION
The influence of sex on adipose tissue distribution and function, and its implication
in metabolic syndrome has been known for a long time (Mayes & Watson, 2004). The
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protective effects of estrogen on adipose tissue activity (D’Eon et al., 2005), and limitation
of its hypertrophic growth (Kumar et al., 2012) and inflammation (Stubbins et al., 2012)
are key sex-related factors, which contribute to limit the disorders elicited by metabolic
syndrome (Antonio et al., 2015). The distribution of fat in gynoid and android shapes
of adult humans is a consequence of the close interrelationship of adipose tissue with
androgens and estrogens (Kotani et al., 1994), modulated by their different response to
glucocorticoids in the aftermath of a tissue defensive response against excess nutrient loads
(Alemany, 2012a).
There are clear differences between females and males in site distribution and metabolic
responses (Porter et al., 2004; Demerath et al., 2007), but most studies on adipose tissue
are limited to a single site or isolated cells, and are usually focused on the responses to
inflammation (Revelo et al., 2014).
The extensive metabolic capability of white adipose tissue (WAT) show a remarkable
uniformity in metabolic function and overall regulation (Carmean, Cohen & Brady,
2014; Romero et al., 2014). As a consequence, the assumed main function of WAT
(i.e., triacylglycerol storage as energy reserve) (Galic, Oakhill & Steinberg, 2010; Romacho et
al., 2014) is been reconsidered because of the multiple functions of this unique disperse
organ (Eringa, Bakker & Van Hinsbergh, 2012; Ferrante, 2013; Giordano et al., 2014).
However, the level of knowledge of WAT metabolism, other than the control of lipid
synthesis and storage, remains remarkably insufficient, constituting a handicap for
interpretation of its physiological role (Jensen, 2007).
WAT contains a complete urea cycle, as shown in the present study, which is, probably
implicated in the extra-splanchnic production of citrulline, a critical factor for muscle
function (Ventura et al., 2013) and inter-organ 2-amino-N transport and utilization.
However, WAT is also a massive producer of 3C fragments, such as lactate (Arriara´n et al.,
2015), but including alanine (Snell & Duff, 1977). WAT is also a net exporter of glutamine
(Kowalski & Watford, 1994), and can use branched-chain amino acids for energy and
lipogenesis (Herman et al., 2010). The large combined organ size, variety of known amino
acid metabolic pathways and diverse physiological functions, hint at WAT as a potentially
important site for peripheral amino acid metabolism. The information available is scant,
we found only a couple of earlier studies (Lo´pez-Soriano & Alemany, 1986; Kowalski, Wu &
Watford, 1997); this is a serious limitation for a full understanding of whether amino acids
should be also included in the well-established role of WAT in the management of energy,
from glucose and lipids.
The little we know of WAT role in amino acid metabolism is further limited by our
almost nil understanding of the role sex plays on WAT metabolism. In general terms,
androgens favor protein deposition (Griggs et al., 1989), and males tend to consume
spontaneously more protein than females (Radcliffe & Webster, 1978); on the other
hand, estrogens lower body weight (Bryzgalova et al., 2008), in spite of females (women)
having—normally—a higher body fat percentage than males (men). Young women are
more resistant to obesity than men (Meyer et al., 2011); however, after menopause, this
estrogenic protection wanes (Cagnacci et al., 2007).
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In this study, we intended to determine whether the gross differences in WAT
distribution and its resilience to change had a robust biochemical basis. Thus, we analyzed
whether the WAT urea cycle and related amino acid catabolic processes of rats showed
sex-modulated differences. To obtain a wider picture we studied the four main (largest)
WAT sites in parallel, and we included in the analysis (for comparison) a number of gene
expressions involved in the control of WAT lipogenesis from glucose and lipolysis.
MATERIALS AND METHODS
Experimental design and animal handling
All animal handling procedures and the experimental setup were in accordance with
the animal handling guidelines of the corresponding European and Catalan Authorities.
The Committee on Animal Experimentation of the University of Barcelona specifically
authorized the procedures used in the present study (DMAH-5483).
The experimental setup consisted on keeping two groups of undisturbed rats (female
and male) under standard conditions for four weeks, in order to limit the influence of
factors other than sex on the parameters analyzed.
Nine week old female and male Wistar rats (Harlan Laboratory Models, Sant Feliu de
Codines, Spain) were used. The rats (N = 6 per group) were housed in pairs (same sex)
in solid-bottom cages with wood shards for bedding. They had free access to water and
ate normal rat chow (type 2014, Harlan). The rats were kept in a controlled environment
(lights on from 08:00 to 20:00; 21.5–22.5 ◦C; 50–60% humidity) for one month.
The rats, without dietary manipulation, were killed, under isoflurane anesthesia, at the
beginning of a light cycle (08:30–10:00), by aortic exsanguination, using dry-heparinized
syringes; then, they were rapidly dissected, taking samples of WAT sites: mesenteric (ME),
perigonadal (epididymal in males, periovaric in females, PG), retroperitoneal (RP) and
subcutaneous (inguinal fat pads, SC). The samples were blotted and frozen with liquid
nitrogen; after weighing, they were ground under liquid nitrogen and stored at −80 ◦C
until processed. Later, the dissection of the rats continued, extracting the remaining WAT
in ME, EP and RP sites; the rats were skinned, and the whole subcutaneous WAT was
dissected. The weights of the recovered WAT were computed only to establish the total
mass of each WAT site.
Blood plasma parameters
The blood obtained from the aorta was centrifuged to obtain plasma, which was frozen and
kept at−80 ◦C until processed. Plasma samples were used to measure glucose (kit #11504),
triacylglycerols (kit #11828), total cholesterol (kit #11505) and urea (kit # 11537), all
from Biosystems, Barcelona Spain. Lactate was measured with another kit (ref. #1001330;
Spinreac, Sant Esteve de Bas, Spain). Amino acids were analysed individually using an
amino acid analyser (Pharmacia-LKB-Alpha-plus, Uppsala, Sweden) from plasma samples
deproteinized with acetone (Arola, Herrera & Alemany, 1977). Since the method used did
not provide fair analyses for glutamine (Gowda, Gowda & Raftery, 2015) and other amino
acids (Trp, Cys, Asn), we decided to present only the partial sum of the other amino acids as
a single indicative value.
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Preparation of tissue homogenates
Frozen tissue samples were homogenized, using a tissue disruptor (Ultraturrax IKA-T10,
Ika Werke, Staufen, Germany), in 5 volumes of chilled 70 mM hepes buffer pH 7.4
containing 1 mM dithiothreitol (Sigma, St Louis MO USA), 50 mM KCl, 1 g/L Triton
X-100 (Sigma) and 1 g/L lipid-free bovine serum albumin (Sigma). In homogenates to
be used for carbamoyl-P synthase 2 estimation, the concentration of Triton X-100 was
halved to decrease foaming. The homogenates were centrifuged for 10 min at 5,000× g;
the floating fat layers and gross debris precipitates were discarded. The clean homogenates
were kept on ice, and used for enzymatic analyses within 2 h of their preparation.
Tissue protein content was estimated with the Lowry method (Lowry et al., 1951). After
development of color, fat droplet suspension-generated turbidity was eliminated with the
addition of small amounts of finely powdered solid MgO before reading the absorbance.
In the measurements of homogenate protein content, homogenization buffer (which
contained albumin) was used as blank. Enzyme activities were expressed in nkat/g protein.
Enzyme activity analyses
Carbamoyl-P synthase was estimated from the incorporation of 14C-bicarbonate (Perkin
Elmer, Bad Neuheim, Germany) into carbamoyl-P using a method previously described
by us (Arriara´n et al., 2012). No significant carbamoyl-P synthase 1 activity was detected
(and its gene was not expressed, either, in WAT). Thus, only carbamoyl-P synthase 2 was
measured.
All other enzyme activities (ornithine carbamoyl-transferase, arginino-succinate
synthase, arginino-succinate lyase and arginases 1 and 2) were estimated following recently
developed methods, which are presented in detail in Supplemental Information 1 both to
justify their adequacy and to allow others to employ a methodology developed for adipose
tissue.
Gene expression analysis
Total tissue RNA was extracted from frozen tissue samples using the Tripure reagent
(Roche Applied Science, Indianapolis IN USA), and was quantified in a ND-100
spectrophotometer (Nanodrop Technologies, Wilmington DE USA). These data were
also used to determine the total RNA content of the tissue (per g of tissue weight or g of
protein) in order to establish comparisons between the quantitative importance of gene
expressions. RNA samples were reverse transcribed using the MMLV reverse transcriptase
(Promega, Madison, WI USA) system and oligo-dT primers.
Real-time PCR (RT-PCR) amplification was carried out using 10 µL amplification
mixtures containing Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City,
CA USA), 4 ng of reverse-transcribed RNA and 150 nmol of primers. Reactions were run
on an ABI PRISM 7900 HT detection system (Applied Biosystems) using a fluorescent
threshold manually set to 0.15 for all runs.
A semi-quantitative approach for the estimation of the concentration of specific gene
mRNAs per unit of tissue/RNA or protein weight was used (Romero et al., 2007). Rplp0 was
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Figure 1 Scheme of the core of amino acid metabolism in WAT: urea cycle and ammonium han-
dling. The abbreviations (marked in red) of the enzymes involved in the pathways depicted are the same
described in Table 1 and throughout this study.
the charge control gene (Eagni et al., 2013). We expressed the data primarily as the number
of transcript copies per gram of protein in order to obtain comparable data between the
groups. The genes analyzed and a list of primers used is presented in Table 1.
Figure 1 depicts a scheme of the relationships between the amino acid metabolism-
related enzymes which gene expressions have been analyzed in this study. This Figure also
shows acronyms or abbreviations of the names of the enzyme-genes used in Figs. 2 and 3.
Sex differences in gene expression
The ample variability of cell volume, blood flow, innervation, size of fat deposits etc. of
WAT poses additional problems for comparison between different anatomical (i.e., site),
physiological (i.e., sex, diet) and pathological (i.e., obesity) situations (Caspar-Bauguil et
al., 2005; Prunet-Marcassus et al., 2006; Gil et al., 2011). The variability of lipid reserves
may convert in irrelevant comparisons based on weight; the use of DNA or cell number
is a better approach, but the multiple types of cells coexisting in WAT (and their widely
variable numbers) may also alter direct comparisons. We used as basic comparison the
protein content, largely because it has been the choice reference for enzyme activity and, by
extension to gene expressions and their possible interactions. However, probably a better
way to measure changes in functional activity may be the analysis of mRNA production.
These changes do not parallel those of weight, protein content or cell numbers, but are
a fair index of the relative importance of translation of the genes involved with respect
to total protein synthesis. In fact, their use is complementary of the analysis of enzyme
activity-gene expression referred to protein weight, since it includes a new variable:
metabolic transcendence for the cell of the synthesis of the corresponding mRNAs. We
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Table 1 Primer sequences used in the analysis of WAT gene expressions.
Protein Gene EC Primer sequence 5′ > 3′ Primer sequence 3′ > 5′ bp
CPS2 Glutamine-dependent carbamoyl-phosphate synthase Cad 6.3.5.5 AGTTGGAGGAGGAGGCTGAG ATTGATGGACAGGTGCTGGT 90
OTC Ornithine carbamoyl transferase Otc 2.1.3.3 CTTGGGCGTGAATGAAAGTC ATTGGGATGGTTGCTTCCT 126
ASS Arginino-succinate synthase Ass1 6.3.4.5 CAAAGATGGCACTACCCACA GTTCTCCACGATGTCAATGC 100
ASL Arginino-succinate lyase Asl 4.3.2.1 CCGACCTTGCCTACTACCTG GAGAGCCACCCCTTTCATCT 104
ARG1 Arginase-1 Arg1 3.5.3.1 GCAGAGACCCAGAAGAATGG GTGAGCATCCACCCAAATG 126
ARG2 Arginase-2 Arg2 3.5.3.1 GCAGCCTCTTTCCTTTCTCA CCACATCTCGTAAGCCAATG 122
NAGS N-acetyl-glutamate synthase Nags 2.3.1.1 GCAGCCCACCAAAATCAT CAGGTTCACATTGCTCAGGA 82
eNOS Nitric oxide synthase, endothelial Nos3 1.14.13.39 CAAGTCCTCACCGCCTTTT GACATCACCGCAGACAAACA 138
GS Glutamine synthetase Glul 6.3.1.2 AACCCTCACGCCAGCATA CTGCGATGTTTTCCTCTCG 148
Gase Glutaminase kidney isoform, mitochondrial Gls 3.5.1.2 CCGAAGGTTTGCTCTGTCA AGGGCTGTTCTGGAGTCGTA 63
GDH1 Glutamate dehydrogenase 1, mitochondrial Glud1 1.4.1.3 GGACAGAATATCGGGTGCAT TCAGGTCCAATCCCAGGTTA 122
GCS Glycine cleavage system H protein, mitochondrial Gcsh – AAGCACGAATGGGTAACAGC TCCAAAGCACCAAACTCCTC 146
AMPD AMP deaminase 2 Ampd2 3.5.4.6 CGGCTTCTCTCACAAGGTG CGGATGTCGTTACCCTCAG 78
AlaT1 Alanine aminotransferase 1 Gpt 2.6.1.2 GTATTCCACGCAGCAGGAG CACATAGCCACCACGAAACC 85
AlaT2 Alanine aminotransferase 2 Gpt2 2.6.1.2 CATTCCCTCGGATTCTCATC GCCTTCTCGCTGTCCAAA 146
BCT1 Branched-chain-amino-acid aminotransferase, cytosolic Bcat1 2.6.1.42 TGCCCAGTTGCCAGTATTC CAGTGTCCATTCGCTCTTGA 138
BCT2 Branched-chain-amino-acid aminotransferase, mitochondrial Bcat2 2.6.1.42 AGTCTTCGGCTCAGGCACT ATGGTAGGAATGTGGAGTTGCT 84
GLUT4 Solute carrier family 2 (facilitated glucose transporter), member 4 Glut4 – CACAATGAACCAGGGGATGG CTTGATGACGGTGGCTCTGC 127
HK Hexokinase-2 Hk2 2.7.1.1 ATTCACCACGGCAACCACAT GGACAAAGGGATTCAAGGCATC 113
G6PDH Glucose-6-phosphate 1-dehydrogenase G6pdx 1.1.1.49 GACTGTGGGCAAGCTCCTCAA GCTAGTGTGGCTATGGGCAGGT 77
ME NADP-dependent malic enzyme Me1 1.1.1.40 TTCCTACGTGTTCCCTGGAG GGCCTTCTTGCAGGTGTTTA 131
PDHK2 Pyruvate dehydrogenase kinase 2, mitochondrial Pdk2 2.7.11.2 TCACTCTCCCTCCCATCAA CGCCTCGGTCACTCATTT 75
PDHK4 Pyruvate dehydrogenase [acetyl transferring] kinase 4, mitochondrial Pdk4 2.7.11.2 GTCAGGCTATGGGACAGATGC TTGGGATACACCAGTCATCAGC 137
CATPL ATP citrate lyase Acly 2.3.3.8 GACCAGAAGGGCGTGACCAT GTTGTCCAGCATCCCACCAGT 96
ACoAC Acetyl-CoA carboxylase 1 Acaca 6.4.1.2 AGGAAGATGGTGTCCGCTCTG GGGGAGATGTGCTGGGTCAT 145
FAS Fatty acid synthase Fasn 2.3.1.85 CTTGGGTGCCGATTACAACC GCCCTCCCGTACACTCACTC 163
PCATl Carnitine palmitoyltransferase 1, liver isoform Cpt1a 2.3.1.21 CCGCTCATGGTCAACAGCA CAGCAGTATGGCGTGGATGG 105
PCATm Carnitine palmitoyltransferase 2, mitochondrial Cpt2 2.3.1.21 TGCTTGACGGATGTGGTTCC GTGCTGGAGGTGGCTTTGGT 152
ACADH Long-chain acyl-CoA dehydrogenase, mitochondrial Acadl 1.3.8.8 ATGCCAAAAGGTCTGGGAGT TCGACCAAAAAGAGGCTAATG 148
ATL Adipose triacylglycerol lipase Atgl 3.1.1.3 CGGTGGATGAAGGAGCAGACA TGGCACAGACGGCAGAGACT 138
HSL Hormone-sensitive lipase Lipe 3.1.1.79 CCCATAAGACCCCATTGCCTG CTGCCTCAGACACACTCCTG 94
LPL Lipoprotein lipase Lpl 3.1.1.34 GAAGGGGCTTGGAGATGTGG TGCCTTGCTGGGGTTTTCTT 103
60S acidic ribosomal protein 0 (housekeeping gene) Rplp0 – GAGCCAGCGAAGCCACACT GATCAGCCCGAAGGAGAAGG 62
A
rriara´n
et
al.(2015),P
eerJ,D
O
I10.7717/p
eerj.1399
6/23
Figure 2 Urea cycle enzyme activities and expressions of their coding genes in four WAT sites of female
and male rats. All data are the mean± sem of 6 animals, and are presented in a log scale. The numerical
data are shown in Tables S1 and S2. Panels in column (A): enzyme activities, red (intense colour) columns
correspond to males and orange (light colour) corresponds to female rats. (B): gene expressions, blue
(intense colour) columns represent the males, and green (light colour) represents the females. CPS2,
carbamoyl-P synthase 2; OTC, ornithine carbamoyl-transferase; ASS, arginino-succinate synthase; ASL,
arginino-succinate lyase; ARG, arginase. Statistical analysis (2-way anova) of the differences between
groups. Activity: there were no significant differences for “sex”; CPS2 and ASL showed P < 0.0001
for “site”. Expression: only CPS2 showed a significant (P = 0.0002) for “sex”: there were significant
differences for “site” in CPS2 and ASL (P < 0.0001), OTC (P = 0.0081), ARG1+ 2 (P < 0.0001); ASS
showed no significant differences. The application of post-hoc Tuckey test between male/female pairs are
shown in the Figure as red stars.
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Figure 3 Expression of genes coding for enzymes of amino acid metabolism in WAT sites of male
and female rats. All data are the mean ± sem of 6 animals, and are presented in a log scale. The
numerical data are shown in Table S3. Blue (dark colour) columns represent the males, and green (light
colour) represents the females. NAGS, N-acetyl glutamate synthase; Ase1, arginase 1; Ase 2, Arginase 2;
eNOS, endothelial nitric oxide synthase; GS, glutamine synthetase; Gase, glutaminase; GDH1, glutamate
(continued on next page...)
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Figure 3 (...continued)
dehydrogenase (NADPH); AMPD, AMP deaminase; AlaT1, alanine transaminase 1; AlaT2, alanine
transaminase 2; BCT1, branched-chain amino acid transaminase 1; BCT2, branched-chain amino acid
transaminase 2. Statistical analysis (2-way anova) of the differences between groups. The variable “sex”
showed global differences for Gase (P < 0.0001), eNOS (P = 0.0014) and AlaT2 (P = 0.0018). The
variable “site” showed significant differences for all genes (P < 0.0001 for eNOS, Gase, GDH1, AMPD,
BCT1 and AlaT2; P= 0.0005 for Ase1; P= 0.0014 for GS; P= 0.0023 for AlaT1, P= 0.024 for BCT2, and
P= 0.039 for GCS) except N-acetyl-glutamate synthase. The application of post-hoc Tuckey test between
male/female pairs are shown in the Figure as red stars between the corresponding columns.
calculated the relationships of gene expressions to total tissue RNA (a crude approximation
to mRNA) only to compare the specific effect of sex on a gene expression in a given site.
Any significant deviation on the proportion of a gene expression with respect to the whole
RNA mass may imply a differential modulation of this expression. We included these
additional data to provide further insight into the ways and means of manifestation of
sex-related differences.
Statistics
Student’s t test (unpaired) and two-way ANOVA comparisons between groups (using
the post-hoc Tuckey test), correlations and curve fitting (including Vi estimations) were
analyzed with the Prism 5 program (GraphPad Software, San Diego CA USA). Data were
presented as mean± sem, and a limit of significance of P < 0.05 was used throughout.
RESULTS
Basic parameters
Table 2 shows the body and main adipose tissue sites weights of undisturbed female
and male animals. When aged 13 weeks, female rats weighed about 62% of their male
counterparts. The males accumulated more fat than females, both in individual sites and as
a whole. However, the sum of the four sites analyzed showed almost identical proportions
vs. body weight, c. 8%. However, there were sex-related individual site differences in
relative size expressed as percentage of body weight. There were also differences in total
protein and RNA proportions (per g of fresh tissue) between the different sites, but there
were no global effects attributable to the variable “sex”.
The main plasma parameters studied are presented in Table 3. Plasma glucose levels
were higher in males than in females. However, these data were influenced by isoflurane
anesthesia (Zardooz et al., 2010), and are presented only as a general indication of
normalcy. No differences were observed for lactate and total cholesterol. Triacylglycerol
levels were significantly higher in females (albeit in the limit of statistical significance).
Both plasma urea and the partial sum of amino acids were also higher in female than in
male rats.
Urea cycle enzymes
Figure 2 depicts urea-cycle enzyme activities and the expression of their corresponding
genes in four main WAT sites of male and female rats. In both cases, activity and gene
expression, the data were presented per g of tissue protein. The data are displayed on a log
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Table 2 Body and WAT site weight and composition of adult male and female Wistar rats. The data
correspond to the mean ± sem of 6 different animals. Statistical significance of the differences between
groups was established with a 2-way anova; post-hoc Tuckey test: an asterisk * represents P < 0.05
differences between sex groups. Comparison of differences between the sums of sites was done using
the Student’s t test.
Parameter Unit Site Male Female p site p sex
Body weight g – 373± 6.1 232± 8.2 – <0.0001
SC 12.2± 0.20* 7.02± 0.25
ME 4.94± 0.49* 3.92± 0.33
PE 7.34± 0.64* 4.83± 0.39
RE 6.29± 0.79* 2.79± 0.35
<0.0001 <0.0001
g
Σ WAT 30.8± 1.7 18.6± 0.93 – <0.0001
SC 3.28± 0.05 3.04± 0.11
ME 1.33± 0.18 1.69± 0.13
PE 1.97± 0.13 2.10± 0.21
RE 1.69± 0.22 1.22± 0.17
<0.0001 NS
WAT weight
% BW
Σ WAT 8.26± 0.47 8.05± 0.52 – NS
SC 63.1± 11.6 51.8± 3.3
ME 74.2± 7.4 84.2± 2.6
PE 44.3± 1.6 54.4± 2.4Protein mg/g
RE 65.1± 6.3 62.9± 4.7
<0.0001 NS
SC 248± 51 219± 19
ME 880± 84 793± 88
PE 94.3± 6.0 119± 10RNA µg/g
RE 48.8± 4.1 78.4± 4.1
<0.0001 NS
Notes.
% BW, Percentage of body weight.
Table 3 Main energy plasma parameters of adult female and male Wistar rats. The data correspond
to the mean + sem of 6 different animals. Statistical significance of the differences between groups was
established with the unpaired Student’s t test.
Parameter Units Male Female P sex
Glucose mM 10.20± 0.42 8.64± 0.34 0.0169
Lactate mM 3.10± 0.29 3.78± 0.24 NS
Total cholesterol mM 1.97± 0.07 1.98± 0.16 NS
Triacylglycerols mM 1.50± 0.06 1.69± 0.06 0.0491
Urea mM 3.90± 0.17 5.13± 0.25 0.0029
Amino acidsa mM 3.34± 0.08 3.96± 0.18 0.0104
Notes.
a This value does not include Gln, Asn, Trp and Cys.
scale to allow a visual comparison of the site patterns of enzyme activities and expressions.
The data used in this representation are also tabulated in numeric form in Tables S1 and
S2. There was a considerable coincidence in the patterns of enzyme activity distribution
(and male–female similarities) in enzyme activities for all four sites. This pattern was
not paralleled by that of the corresponding gene expression data, which also showed
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considerable uniformity in their patterns across the WAT sites. The statistical analysis
of the data in Fig. 2 showed significant differences for “site” for all enzyme expressions
except for arginino-succinate synthase. The site-related differences in enzyme activities,
however, were limited to arginino-succinate lyase and carbamoyl-P synthase.
Subcutaneous WAT showed more differences between sexes than other locations, affect-
ing carbamoyl-P synthase 2 (both activity and gene expression) and arginino-succinate
lyase (only activity). Arginino-succinate synthase activity showed differences between
females and males in mesenteric WAT, and its higher expression was observed in periovaric
WAT.
Other amino acid metabolism-related gene expressions
Figure 3 shows the gene expressions of the non-urea cycle enzymes presented in Fig. 1,
as well as differentiated arginases 1 and 2, which were combined in Fig. 2. The data are
depicted also on a log scale to facilitate pattern comparison; the corresponding numerical
results are shown in Table S3.
In all sites, the expression of e-NOS was, at least one order of magnitude higher than
arginase; subcutaneous WAT being an exception: despite showing a similar pattern of
expressions, the levels of mRNA per g of tissue protein were higher for most genes, in
subcutaneous WAT, than in the other three sites. There was a generalized predominance
of glutamine synthetase expression over that of glutaminase. The glycine cleavage
system (specifically the H protein of the complex) and AMP deaminase showed also
a robust expression, at levels comparable to those of alanine transaminases. The two
branched-chain amino acid transaminases were also within this range, but the expression
of the form 2 was much higher.
The statistical comparisons of the data in Fig. 3 present limited effects for sex; overall
only nitric oxide synthase, alanine transaminase 2 and glutaminase showed significant
overall differences between female and male rats. Paired sex-related differences were
concentrated in subcutaneous WAT, with higher male values in the expression of
nitric oxide synthase, glutamine synthase (but female-predominant glutaminase), AMP
deaminase and alanine transaminase 1. No sex-related differences were found in the
other sites, except higher male values in alanine transaminase 2 of perigonadal WAT. The
differences between sites, however, were more marked, affecting all genes studied except
N-acetyl-glutamate synthase (low expression) and arginase 2, which was expressed only in
subcutaneous WAT.
Gene expressions of proteins involved in WAT acyl-glycerol
metabolism
Figure 4 presents the gene expressions of the key transporter and enzymes that regulate
the lipogenic process from glucose to acetyl-CoA and from that metabolite to acyl-CoA,
including the three most important WAT lipases. The data are presented in a log scale
and the numerical data are shown in Table S4. In spite of a considerable uniformity in the
patterns for all four sites, there were marked differences in the extent of gene expression.
In general, subcutaneous WAT values were higher, than those of the other sites. Again,
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Figure 4 Expression of genes coding for transporter and enzymes related to lipogenesis from glucose
and catabolism of lipid stores in WAT sites of male and female rats. All data are the mean ± sem
of 6 animals, and are presented in a log scale. The numerical data are shown in Table S4. Blue (dark
colour) columns represent the males, and green (light colour) represents the females. GLUT4, glucose
transpoirter 4; HK, hexokinase; G6PDH, glucose-6P dehydrogenase; ME, malic enzyme; (continued on
next page...)
Arriara´n et al. (2015), PeerJ, DOI 10.7717/peerj.1399 12/23
Figure 4 (...continued)
PDHK2, pyruvate dehydrohenase kinase 2; PDHK4, pyruvate dehydrohenase kinase 4; CATPL, citrate:
ATP lyase; AcCoAC, acetyl-CoA carboxylase; FAS, fatty acid synthase; PCATl, palmitoleoyl-carnitine
acyl-transferase (liver); PCATm, palmitoleoyl-carnitine acyl-transferase (muscle); AcADH, acyl-CoA de-
hydrogenase; ATL, adipose triacylglycerol lipase; HSL, hormone-sensitive lipase; LPL, lipoprotein lipase.
Statistical analysis (2-way anova) of the differences between groups. The variable “sex” showed global
differences for HK (P = 0.0009), AcCoAC (P = 0.0035), GLUT4 (P = 0.0040), CATPL (P = 0.010),
G6PDH (P = 0.020), PHDK4 (P = 0.020), ME (P = 0.024) and ATL (P = 0.026). The variable “site”
showed significant differences for HSL, ATL and LPL (P < 0.0001), PCATl (P = 0.0004), G6PDH
(P= 0.0005), PDHK2 (P= 0.0013). PDHK4 (P= 0.0016), ACADH (0.0022), HK (P= 0.0057), PCATm
(P = 0.015) and AcCoAC (P = 0.0384). The application of post-hoc Tuckey test between male/female
pairs are shown in the Figure as red stars (P < 0.05).
overall (for mesenteric, retroperitoneal and perigonadal WAT), female expression values
tended to be higher than those of the males for genes coding proteins favoring glucose
incorporation (GLUT4, hexokinase), generation of NADPH (glucose-6P dehydrogenase,
malic enzyme), and lipogenesis (citrate: ATP lyase, and acetyl-CoA carboxylase).
Regulation of pyruvate dehydrogenase by its inhibiting kinases was higher in males,
suggesting a lower mitochondrial availability of acetyl-CoA. In males, mitochondrial
handling of fatty acids (carnitine palmitoleoyl-transferases, acyl-CoA dehydrogenases) and
lipolysis (except adipose triacylglycerol lipase) showed higher relative expressions than in
females.
Subcutaneous WAT showed higher expression values for males in pyruvate dehydro-
genase kinase 4, palmitoleoyl.carnitine acyl-transferase (liver), acyl-CoA dehydrogenase
and both lipoprotein and adipose triacylglycerol lipases. In mesenteric WAT, the only
significant difference was for higher malic enzyme expression in females. In retroperitoneal
WAT, female expression values were higher for malic enzyme, citrate: ATP lyase and
acetyl-CoA carboxylase. Again, in perigonadal WAT, female expression values were higher
for glucose-6P dehydrogenase. The overall differences for “site” were significant for all
genes investigated except for GLUT4, malic enzyme, citrate: ATP lyase and fatty acid
synthase.
Comparison of female and male gene expression
Table 4 summarizes the sex-related differences in gene expression. The data are presented
in two cooperative forms: expression per unit of protein and per unit of RNA weight
in the tissue. The corresponding numerical data for RNA data and complete statistical
analysis are shown on Table S5. Table 4 shows only the cases where female–male differences
were significant, and the genes are divided in four sections. In the first, corresponding to
urea-cycle enzymes, only carbamoyl-P synthase 2 of subcutaneous WAT showed higher
female than male values. No other differences were seen. There was a high degree of
superimposition between the data obtained from protein and RNA; but the number of
enzymes with statistically significant between sexes was higher in most WAT sites when the
data of reference was RNA than when related to tissue protein.
Other amino acid metabolism data showed a relative predominance of higher relative
expressions in males, especially affecting the transaminases. The sites with more differences
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Table 4 Comparison of male-female specific expression of genes in different WAT sites with respect
to tissue total protein or RNA. The data are the mean ± sem of 6 animals per group, and are expressed
as fmol of the corresponding gene mRNA per g of protein or mg of total RNA. The complete numerical
data Table for RNA is presented in Table S5. Only significant differences are shown. M > F represents
that male data were significantly higher than those of females; F > M represented that female data were
significantly higher than those of males. Analysis of significance was done using 1- and 2-way anovas
(the latter for combined sites). The data in regular font correspond to significant values in the expression
of fmol/mg RNA, those in italics correspond to the data which were significant only when expressed as
fmol/g protein. The data in bold correspond to differences statistically significant both when referred to
tissue protein and RNA.
Parameter WAT site All sites P
SC ME PG RP
urea cycle enzymes
Carbamoyl-P synthase 2 F>M – – – F>M
Ornithine carbamoyl-transferase – – – – –
Argininosuccinate synthase – – – – –
Argininosuccinate lyase – – – – –
Arginase 1 – – – – –
other enzymes of amino acid metabolism
N-acetyl-glutamate synthase M>F – – – –
Glutamate dehydrogenase 1 – – – – –
Glutamine synthetase M>F – – – M>F
Glutaminase F>M F>M – – F>M
AMP deaminase M> F – – – M>F
Glycine cleavage system – – F>M – –
Alanine transaminase 1 M> F – – M>F M>F
Alanine transaminase 2 M>F – M> F M>F M> F
Branched-chain amino acid transaminase 1 – – M>F M>F M>F
Branched-chain amino acid transaminase 2 – – – – –
Endothelial nitric oxide synthase M> F – – M>F M> F
enzymes (and transporters) related with lipogenesis from glucose
Glucose transporter 4 – – – F>M F>M
Hexokinase 2 – – F>M F>M F>M
Glucose-6P dehydrogenase – F>M F>M F>M F>M
Malic enzyme – F>M F>M F>M F>M
Pyruvate dehydrogenase kinase 2 M>F – – M>F M>F
Pyruvate dehydrogenase kinase 4 M> F – – M>F M> F
Citrate: ATP lyase – F>M – F>M F>M
Acetyl-CoA carboxylase F>M F>M – F>M F>M
Fatty acid synthase – F>M F>M F>M F>M
(continued on next page)
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Table 4 (continued)
Parameter WAT site All sites P
SC ME PG RP
enzymes (and transporters) related with lipolysis and fatty acid oxidation
Carnitine palmitoleoyl transferase (liver) M> F – M>F M>F M>F
Carnitine palmitoleoyl transferase (muscle) – – – – M>F
Long-chain acyl-CoA dehydrogenase M> F F>M – – M>F
Adipose tissue triacylglycerol lipase F> F – – M>F M> F
Hormone-sensitive lipase – – – – M>F
Lipoprotein lipase M> F – – M>F –
were subcutaneous and retroperitoneal WAT. In contrast, lipogenesis was more highly
expressed in females, with minimal effects on subcutaneous and highest in retroperitoneal
WAT. Male predominance was observed again on pyruvate dehydrogenase kinases’
expressions, which increase marks a lower rate of production of acetyl-CoA as substrate
for acyl-CoA synthesis. Finally, in the analysis of lipolytic and lipid oxidation-related genes,
the male higher values were the norm, especially in subcutaneous and retroperitoneal
WAT.
DISCUSSION
The results presented support a wide extension of amino acid metabolism in different
sites of WAT, with enzyme activities and expressions following similar patterns in all four
sites studied. In addition to urea cycle, AMP-deaminase (Arola et al., 1981a), glutamine
synthetase (Arola et al., 1981b), glutamate dehydrogenase (Arola et al., 1979) and nitric
oxide synthase (Pilon, Penfornis &Marette, 2000), we found that WAT expresses the glycine
cleavage system (at least the H protein), so far not described.
The metabolic capabilities of WAT with respect to amino acid metabolism are probably
more extensive than usually assumed (Alemany, 2012b), largely because it is unknown,
with scant literature references to WAT amino acid metabolism (Lo´pez-Soriano & Alemany,
1986; Kowalski, Wu &Watford, 1997; Herman et al., 2010; Lackey et al., 2013). The range
of expressions observed for amino acid metabolism-related enzymes in the four WAT
sites studied (Figs. 2 and 3) was mostly in the 5–500 fmol/g protein. In comparison, the
expressions (Fig. 4) for lipogenesis, the (assumed) main metabolic function of WAT,
and other lipid metabolism-related expressions were in the range of 10-1,000 fmol/g
protein. Thus, the differences between lipogenesis and amino acid metabolism-related
gene expressions were not as extensive as expected from the known massive mobilization/
deposition of triacylglycerols in adipocytes, compared with the relatively low level of cell
proteins (Salans & Dougherty, 1971) (and cytoplasm) of WAT. This is compounded by the
lack of sufficient data on WAT amino acid metabolism above indicated. The relatively
elevated amino acid metabolism enzyme levels and gene expressions found hint at a
potential relative importance of WAT on body amino acid metabolism.
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The considerable uniformity of WAT urea cycle-enzyme activities and expressions,
and their marked independence of sex can be interpreted essentially in two ways: (a) as
playing a minimal metabolic role: i.e., a residual, secondary or specialized pathway. Or,
alternatively, (b), it can be assumed to be a consequence of a well-established and robust
homeostatic maintenance of its function. That is, a role critical enough not to be sensibly
influenced by external regulatory factors such as sex hormones. The first possibility may
seem the more obvious, but it is insufficient to counter a number of critical arguments:
first of all, the unexpectedly high level of enzyme expressions and activities. Individual
urea cycle enzymes are present in many tissues, Emmanuel (1980), Nishibe (1974), and
Rath et al. (2014). However, the mere existence of a complete urea cycle in a peripheral
organ outside the splanchnic bed has not been previously described, as far as we know.
A full operative urea cycle has been described only for liver (Emmanuel, 1980). The key
question is whether this cycle is functional or not. Due to its methodological difficulties,
it should be studied using other (i.e., tracer) techniques. However, the relatively high
enzyme activities and gene expressions observed, and the fact that all urea cycle and related
ammonium metabolism enzymes are present suggest that this distribution has a clear
functional purpose. This is, consequently, a situation different from that of tissues, which
contain only part of the cycle to serve other metabolic purposes. The lack of sex-related
differences in WAT sites of urea cycle compared with lipogenic processes, as shown in Figs.
2–4 and the remarkable uniformity in pattern distribution between WAT sites also support
the functionality of WAT urea cycle.
The varying ratios of activity/expression suggest a main post-translational control,
extended to all sites. The high ornithine carbamoyl-transferase vs. arginino-succinate
synthase activities suggest a probable implication in the peripheral (and critical) synthesis
of citrulline (Yu et al., 1996), which may complement its conversion by the kidney (Borsook
& Dubnoff, 1941). WAT participates in substrate cycles, including alanine synthesis (Snell
& Duff, 1977) and glutamine release (Kowalski &Watford, 1994) in which amino acids are
implicated. This analysis is further complicated by the quantitative importance of both
activity and gene expressions compared with those of lipogenesis, the mainstay of WAT
metabolism. Our understanding of these differences is complicated by the overall large size
of the adipose organ (Romero et al., 2014), even taking into account the metabolically inert
mass of fat. Taken together, these arguments support a significant role of WAT in amino
acid metabolism.
Our data suggest, in any case, a clear site-sex interaction (Lemonnier, 1972; Jaubert et al.,
1995) that brings up differences in the expression of several amino acid metabolism-related
genes other than urea cycle, which remains uncannily undisturbed and globally uniform.
In males, subcutaneous WAT shows higher expressions for genes related to transfer of
acyl-CoA to the mitochondria and its oxidation than females; this is consistent with the
possibility of using fatty acids as energy substrate. The higher male inhibition of pyruvate
dehydrogenase, by kinases, generalized to most sites, reinforces this trend. On the other
side, the expression of WAT lipogenic enzyme genes (especially when expressed with
respect to total RNA) was higher in females than in males. In contrast, lipases practically
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did not show differences. The different female-male specific metabolic predominance in
WAT sites prove that the limited changes in urea cycle, compared with lipogenesis, could
not be solely a consequence of overall lack of effects of sex on WAT; but it is, instead, a
specific characteristic of WAT urea cycle as compared to other metabolic pathways.
The higher lipogenic (and lower lipolytic) gene expressions of female WAT is counter-
intuitive when we think of the higher WAT mass of adult male rats (Romero et al., 2014).
Probably, the lower male gene expressions found here mirror a less active metabolism, in
conjunction with the intestine and liver. The visceral fat accumulation in adult men (Bosch
et al., 2015) as compared with women is correlated with insulin resistance (Pascot et al.,
2000) and other metabolic syndrome-related pathologies (Watanabe & Tochikubo, 2003).
The discordances in sex-related control of metabolism and fat deposition between humans
and rats are a critical caveat against generalization to humans of what is found using animal
models, in spite of shared mechanisms and trends.
In addition to the human-rodent question, the main limitation of this study is the lack
of previous data with which establish comparisons, made even more difficult by our scarce
knowledge of amino acid metabolism. The extensive and interconnected net of pathways
needs to be investigated. The most critical handicap, however, is the lack of a critical
mass of scientists and of actualized methodology: specific protein measurement reagents
(antibodies), and/or methods (and products) for the estimation of enzyme activities and
metabolites of amino acid metabolism. Consequently, the data we present here should be
taken as just an initial foray into a highly promising field of study.
An additional question may help explain the differences between sites (Lemonnier, 1972;
Ryde´n et al., 2014), and the influence of sex (and sex hormones), the differences in cell
populations of different WAT sites. A factor that affects the mean adipocyte size (also
influenced by obesity (Garaulet et al., 2006)) and the presence of other types of cells, in
different proportions, such as macrophages (Kra´lova´ Lesna´ et al., 2015), stem cells (Ogura
et al., 2014) and other stromal components (Maumus et al., 2011).
Notwithstanding these caveats, the data gathered all point to a few preliminary
conclusions, which could not be yet fully proven with the data we presented, largely
because no other results are available for comparison or independent confirmation. The
potential for lipid handling of WAT sites was strongly modulated by sex, being considerably
dependent on the site studied. This part of the study, devised to provide a background
comparison for amino acid metabolism showed more extensive differences than expected,
and needs to be studied more specifically and deeply before sufficiently based conclusions
could be extracted.
There was a considerable stability of the urea cycle activities and expressions,
irrespective of sex, and with only limited influence of site. Which we interpret as this
cycle operation being more general than the specialized site metabolic peculiarities,
with robust control of WAT urea cycle, probably related to a possible role as provider of
arginine/ citrulline (Beliveau Carey et al., 1993). The resilience to change of urea cycle,
in the context of a tissue characterized by its plastic adaptability, supports a generalized,
probably essential, role in overall amino N handling.
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In contrast, sex affected deeply WAT ammonium-centered amino N metabolism in
a site-related fashion, with relatively higher levels of activity in males and in female
subcutaneous WAT. The data on amino acid catabolism fit also with a role of mesenteric
WAT as gatekeeper of the portal system, the hypothesis advanced for WAT glucose disposal
(Arriara´n et al., 2015) can be easily translated to the management of possible transient
excesses of dietary amino acids.
In sum, WAT seems to play significant role in overall amino acid metabolism, including
a functional urea cycle, which is not affected by sex. Contrary to lipid/glucose-related
pathways, the data presented point to a centralized control of urea cycle operation affecting
the adipose organ as a whole.
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SUPPLEMENTAL MATERIAL 
SUPPLEMENTAL METHODS 
 
Measurement of urea cycle enzyme activities 
 
 Ornithine carbamoyl transferase activity was 
measured from the reaction of condensation of 
carbamoyl-P and 14C-ornithine to yield 14C-citrulline. 
Aliquots of 25 μL of homogenates were mixed with 50 
μL of 70 mM hepes buffer pH 7.4 containing carbamoyl-
P, ornithine (all from Sigma), and 14C-ornithine (Perkin-
Elmer); final concentrations were 9 mM, 13 mM and 1 
kBq/mL, respectively. The reaction was started with the 
homogenate, and was carried out at 37ºC. Aliquots of 75 
μL were introduced in tubes containing 100 μL of chilled 
acetone, in ice, at 0, 0.5,1 and 2 min. The tubes were 
later centrifuged to obtain clear supernatants; they were 
dried in a vacuum-centrifuge (Thermo Scientific, 
Waltham, MA USA). The dry residues were dissolved in 
25 μL of pure water; they were applied to silicagel TLC 
plates (200 µm; Macherey-Nagel, Düren, Germany), 
etched vertically to define 1 cm wide lanes to prevent 
sample overlapping. Standards of ornithine and citrulline 
were included each plate. The plates were developed 
with a mobile phase of trichloromethane: methanol: 
acetic acid (1:2:2 by volume). After drying, the lane with 
non-labelled standards was sprayed with ninhydrin, and 
heated with a hair dryer. The ornithine and citrulline 
spots were marked and the plate was cut in horizontal 
zones, which were counted. To limit interferences , the 
label in the citrulline area was expressed as a 
percentage of the total label counted in each TLC lane. 
These data allowed the calculation of newly formed 
citrulline; the Vi value for each sample was plotted, and 
considered to be an expression of Vmax under the 
conditions tested.  
 Arginino-succinate synthase activity was 
measured from the condensation of aspartate with 
citrulline in the presence of ATP to yield 
argininosuccinate. Aliquots of 55 μL of homogenates 
were mixed with 30 μL of 70 mM hepes buffer pH 7.4, 
containing ATP-Na2, MgCl2, citrulline, aspartate (all from 
Sigma); final concentrations were 10 mM, 5 mM, 3 mM, 
and 2.5 mM, respectively. The reaction was started with 
aspartate, and was carried out at 37ºC. The reaction 
was stopped with 40 μL of 30 g/L perchloric acid. The 
tubes were vortexed and immediately neutralized (pH 7-
8) with 10 μL of 100 g/L KOH containing 62 g/L 
potassium bicarbonate. The tubes were vortexed again 
and centrifuged at 8,000xg for 15 min and 4ºC. The 
aspartate remaining in the supernatants was measured 
(by transamination to oxaloacetate, and then reduced by 
malate dehydrogenase and NADH). Briefly, 20 μL of the 
supernatants were brought up to 300 μL in 96-well 
plates, with 66 mM phosphate buffer pH 7.4 containing 
NADH, 2-oxoglurarate, aspartate transaminase (pig 
heart) and malic acid dehydrogenase (pig heart) (all 
from Sigma); final concentrations were, respectively, 
0.25 mM, 0.2 mM, 20 nkat/ml and 17 nkat/ml. The 
samples were read at 340 nM in a plate reader (Biotek, 
Winoosky, VT USA) for 30 min at intervals of 30 s. The 
fall in NADH was used to determine the levels of 
aspartate at each incubation time. Its disappearance 
(versus time zero levels) was used to determine the 
amount of aspartate incorporated into argininosuccinate. 
As in the case of ornithine carbamoyl transferase, the Vi 
values were plotted for each sample. In all series, a 
number of samples were analyzed with all reagents 
except citrulline: No spurious consumption of aspartate 
was observed  
 The activity of argininosuccinate synthase was 
measured from the breakup of argininosuccinate to yield 
fumarate and arginine. This amino acid was measured 
in a second reaction using arginase to form ornithine 
and urea, which was analyzed using a chemical method. 
Aliquots of 38 μL of homogenates were mixed with 38 
μL of 70 mM hepes buffer pH 7.4, containing 
argininosuccinate (Sigma); final concentration 2 mM. 
Incubations were carried out at 37ºC for 0, 2.5, 5 and 10 
min. The reaction was stopped by the addition of 40 μL 
of 30 g/L perchloric acid. The tubes were vortexed and 
brought to pH 8-9 with 10 μL of 100 g/L KOH containing 
80 g/L potassium bicarbonate. The tubes were mixed 
again, and centrifuged for 15 min in the cold (4ºC) at 
8,000xg. Aliquots of 100 μL of the supernatants were 
mixed with 50 μL of the reacting mixture: 70 mM hepes 
buffer pH 7.5 (to achieve a final pH 8.5) containing 
MnCl2 and arginase (rat liver, Lee Biosolutions, St Louis, 
MO USA); final concentrations 7 mM and 17 nkat/mL. 
The buffer containing Mn and arginase was activated 
(heated) for 5 min at 55ºC before use. The reaction was 
allowed to develop for 30 min at 37ºC, and was stopped 
by the addition of 35 μL 160 g/L perchloric acid. The 
tubes were centrifuged for 15 min at 8,000xg and 4ºC. 
The acidic supernatants (175 μL) were used for the 
estimation of urea. They were mixed with 300 μL of 90 
g/L H2SO4 containing 270 g/L H3PO4; then 20 μL of 30 
g/L of 1-phenyl-2-oxime-1,2-propanodione (Sigma) in 
absolute ethanol were added (MC). The reaction was 
developed at 100ºC for 30 min in a dry block heater. The 
absorbance of the tubes was measured at 540 nm using 
a plate reader, including standards of arginine and urea 
as well as blanks. Under these conditions, conversion of 
arginine to urea was complete. 
 Total arginase activity was measured through the 
estimation of the urea produced from arginine in the 
presence of Mn2+ (MG). Aliquots of 20 μL of 
homogenates were mixed with 5 μL of 50 mM MnCl2. 
The tubes were heated for 5 min at 55ºC to activate 
arginase (MH). Then, the temperature was brought 
down to 37ºC. The reaction began with the addition of 
75 μL of arginine (Sigma); final concentration 78 mM. 
Incubations were carried out for 1, 10 and 20 min at 
37ºC. The reaction was stopped by the addition of 35 μL 
160 g/L perchloric acid. The tubes were centrifuged at 
8,000xg and 4ºC for 15 min. The measurement of urea 
generated was done as described above for 
argininosuccinate lyase. Since the method used for 
arginase does not differentiate between arginases 1 and 
2, we present a combined total arginase value that 
corresponds mostly to arginase 1 (expressed in all WAT 
sites, whilst arginase 2 was expressed only in SC WAT). 
 
 
SUPPLEMENTAL TABLES 
 
Supplemental Table 1 Urea cycle enzyme activities in WAT sites of female and male Wistar rats 
 
enzyme units sex SC ME RP PG P (site) P (sex) 
glutamine-dependent carbamoyl-
phosphate synthase 
nkat/gP 
M 165 ± 35* 49.0 ± 13.7 56.5 ± 9.2 40.4 ± 9.3 
<0.0001 NS 
F 88.0 ± 30.8 55.3 ± 6.7 61.6 ± 9.9 53.8 ± 13.3 
ornithine carbamoyl transferase 
M 2434 ± 1108 2792 ± 872 3206 ± 403 1975 ± 496 
NS NS 
F 3871 ± 981 2051 ± 598 3015 ± 579 2585 ± 727 
argininosuccinate synthase 
M 82 ± 11.4 57.3 ± 8.5 73.8 ± 15.3 87.8 ± 17.7 
NS NS 
F 51.7 ± 7.5 114 ± 15.4* 40.7 ± 13.1 61.2 ± 9.0 
argininosuccinate lyase 
M 291 ± 40 170 ± 33 90.1 ± 6.7 147 ± 35 
<0.0001 NS 
F 501 ± 108* 166 ± 37 79.8 ± 10.3 162 ± 42.3 
arginase (total) 
M 435 ± 103 220 ± 50 297 ± 168  361 ± 117 
NS NS 
F 316 ± 82 232 ± 32 335 ± 64 337 ± 51 
 
The data are the mean ± sem of 6 animals per group. Statistical significance of the differences between groups was established with a 2-way anova; post-hoc 
Tuckey test: different superscript letters represent P<0.05 differences  
 
Supplemental Table 2 Urea cycle enzyme gene expressions in WAT sites of female and male Wistar rats 
 
enzyme (gene)  units sex SC ME RP PG P (site) P (sex) 
glutamine-dependent carbamoyl-
phosphate synthase, type 2 (Cad) 
fmol/gP 
 
M 58.3 ± 7.9 56.3 ± 6.3 12.8 ± 1.9 43.0 ± 4.2 
<0.0001 0.0002 
F 95.6 ± 4.7* 63.4 ± 6.1 24.5 ± 5.9 55.0 ± 5.9 
ornithine carbamoyltransferase (Otc) 
M 2.99 ± 0.95 0.19 ± 0.02 0.76 ± 0.32 0.91 ± 0.13 
0.008 NS 
F 1.17 ± 0.07 0.23 ± 0.07 1.35 ± 0.57 2.19 ± 0.94 
argininosuccinate synthase 1(Ass1) 
M 10.2 ± 1.8 4.68 ± 0.61 3.62 ± 1.12 5.02 ± 0.35 
NS NS 
F 6.39 ± 0.71 5.96 ± 1.01 5.58 ± 1.84 13.4 ± 5.4* 
argininosuccinate lyase (Asl) 
M 57.1 ± 8.4  27.3 ± 5.7 10.3 ± 2.4 36.0 ± 4.4 
<0.0001 NS 
F 44.9 ± 2.4 34.5 ± 4.9 14.8 ± 1.5 28.0 ± 2.8 
arginase  (Arg1 + Arg2) 
M 21.2 ± 1.7* 0.74 ± 0.24 0.39 ± 0.15 2.74 ± 0.56 
<0.0001 NS 
F 16.1 ± 2.1 0.41 ± 0.04 1.59 ± 0.50 3.23 ± 0.67 
 
The data are the mean ± sem of 6 animals per group. Statistical significance of the differences between groups was established with a 2-way anova; post-hoc 
Tuckey test: different superscript letters represent P<0.05 differences: "Total" arginase is the composite value of the sums of expressions of the genes for 
arginases 1 and 2, affecting only SC data, since in the other sites, only arginase 1 was detected. The separate data for arginases is shown in Supplemental 
Table 3.  
Supplemental Table 3 Amino acid metabolism enzyme gene expressions in WAT sites of female and male Wistar rats 
 
enzyme (gene)  sex SC ME RP PG P (site) P (sex) 
N-acetylglutamate synthase (Nags) 
M 1.13 ± 0.31 0.85 ± 0.32 0.43 ± 0.04 0.96 ± 0.15 
NS NS 
F 0.88 ± 0.25 1.04 ± 0.33 0.97 ± 0.08 1.21 ± 0.32 
arginase-1 (Arg1) 
M 3.29 ± 1.08 0.74 ± 0.24 0.39 ± 0.15 2.74 ± 0.56 
0.0042 NS 
F 4.25 ± 1.38 0.41 ± 0.04 1.59 ± 0.50 3.23 ± 0.67 
arginase-2, mitochondrial (Arg2) 
M 17.9 ± 2.4 -- -- -- 
-- -- 
F 11.1 ± 2.7 -- -- -- 
nitric oxide synthase, endothelial (Nos3) 
M 75.4 ± 9.5* 21.6 ± 2.6 14.6 ± 1.1 31.6 ± 6.3 
<0.0001 0.0031 
F 43.2 ± 2.8 18.5 ± 1.0 16.1 ± 2.2 22.6 ± 2.4 
glutamine synthetase (Glul) 
M 1336 ± 523* 198 ± 29 136 ± 9 426 ± 99 
0.0005 NS 
F 461 ± 49 225 ± 38 186 ± 39 308 ± 42 
glutaminase kidney isoform, mitochondrial (Gls) 
M 39.9 ± 4.8 20.1 ± 1.5 15.4 ± 1.1 24.2 ± 2.7 
<0.0001 <0.0001 
F 77.5 ± 6.4* 24.4 ± 2.9 22.2 ± 2.7 23.6 ± 3.6 
glutamate dehydrogenase 1, mitochondrial (Glud1) 
M 451 ± 80 410 ± 62 119 ± 13 272 ± 32 
<0.0001 NS 
F 350 ± 37 454 ± 62 170 ± 13 300 ± 11 
glycine cleavage system H protein, mitochondrial 
(Gcsh) 
M 110 ± 15 60.6 ± 11.8 45.8 ± 3.9 72.9 ± 12.2 
NS NS 
F 109 ± 31 62.8 ± 7.8 86.1 ± 15.2 90.1 ± 5.2 
AMP deaminase 2 (Ampd2) 
M 125 ± 21* 56.4 ± 14.6 14.5 ± 1.3 32.9 ± 3.6 
<0.0001 NS 
F 73.5 ± 6.7 83.9 ± 9.9 22.0 ± 2.4 32.4 ± 2.7 
alanine aminotransferase 1 (Gpt) 
M 434 ± 104* 156 ± 53 115 ± 10 325 ± 41 
0.0033 NS 
F 193 ± 31 191 ± 49 163 ± 31 268 ± 39 
alanine aminotransferase 2 (Gpt2) 
M 10.1 ± 2.2  4.76 ± 1.68 4.52 ± 0.69 21.7 ± 3.7* 
<0.0001 0.0018 
F 6.72 ± 1.02 3.86 ± 0.97 4.15 ± 1.00 9.03 ± 1.59 
branched-chain-amino-acid aminotransferase, 
cytosolic (Bcat1) 
M 13.5 ± 1.8 14.9 ± 0.9 3.15 ± 0.43 12.7 ± 2.5 
<0.0001 NS 
F 13.6 ± 3.0 14.4 ± 3.3 3.20 ± 0.42 8.31 ± 0.95 
branched-chain-amino-acid aminotransferase, 
mitochondrial (Bcat2) 
M 176 ± 49 132 ± 33 56.7 ± 5.0 142 ± 37 
0.0344 NS 
F 113 ± 18 114 ± 20 80.5 ± 6.3 142 ± 7 
 
The data are the mean ± sem of 6 animals per group, and are expressed as  fkat/g of protein. Statistical significance of the differences between groups was established with a 
2-way anova; post-hoc Tuckey test: different superscript letters represent P<0.05 differences. The data for arginase 2 were compared with an 1-way anova test and pos 
  
 
Supplemental Table 4 Lipid metabolism-related protein gene expressions in WAT sites of female and male Wistar rats 
 
protein (gene)  sex SC ME RP PG P (site) P (sex) 
solute carrier family 2 (facilitated glucose transporter), member 
4 
M 108 ± 29 31.2 ± 8.6 44.0 ± 6.5 109 ±8.1 
NS 0.0040 
F 160 ± 18 116 ± 36 119 ± 43 160 ± 54 
hexokinase-2 (Hk2) 
M 11.7 ± 2.5 7.89 ± 1.18 4.12 ± 0.39 16.9 ± 2.8 
0.0057 0.0009 
F 18.9 ± 3.7 16.8 ± 3.2 13.5 ± 4.5 25.6 ± 5.7 
glucose-6-phosphate 1- dehydrogenase (G6pdx) 
M 334 ± 73 129 ± 18 84.2 ± 14.2 129 ± 12 
0.0005 0.0196 
F 267 ± 25 202 ± 32 183 ± 35 285 ± 51* 
NADP-dependent malic enzyme (Me1) 
M 1672 ± 684 47.3 ± 13 110 ± 27 120 ± 28 
NS 0.0244 
F 725 ± 200 1251 ± 379* 1361 ± 307* 721 ± 255 
pyruvate dehydrogenase kinase 2, mitochondrial (Pdk2) 
M 269 ± 87 120 ± 24 48.6 ± 7.6 91.7 ± 12.8 
0.0013 NS 
F 146 ± 13 193 ± 51 63.9 ± 10.4 86.8 ± 16.8 
pyruvate dehydrogenase [acetyl transferring] kinase 4, 
mitochondrial (Pdk4) 
M 180 ± 73* 14.2 ± 3.7 13.5 ± 3.5 14.5 ± 5.4 
0.0016 0.0203 
F 22.7 ± 2.6 7.64 ± 3.86 6.10 ± 1.00 8.52 ± 3.29 
ATP citrate lyase (Acly) 
M 167 ± 81 22.2 ± 2.9 25.1 ± 4.7 109 ± 10 
NS 0.0100 
F 186 ± 54 160 ± 34 295 ± 140* 228 ± 102 
acetyl-CoA carboxylase 1 (Acaca) 
M 74.0 ± 16.3 30.6 ± 3.9 81.0 ± 7.2 126 ± 12 
0.0038 0.0035 
F 149 ± 37 165 ± 49 542 ± 206* 156 ± 66 
fatty acid synthase (Fasn) 
M 7620 ± 4114 191 ± 74 572 ± 85 1269 ± 250 
NS NS 
F 2447 ± 403 1657 ± 536 3318 ± 1130 2106 ± 795 
carnitine palmitoyltransferase 1, liver isoform (Cpt1a) 
M 39.6 ± 14.8* 14.0 ± 2.7 3.31 ± 0.51 16.3 ± 1.7 
0.0002 NS 
F 19.4 ± 3.9 13.7 ± 3.6 2.02 ± 0.36 10.8 ± 1.7 
carnitine palmitoyltransferase 2, mitochondrial (Cpt2) 
M 10.6 ± 3.0 10.7 ± 1.5 13.4 ± 1.7 25.1 ± 4.3 
0.0150 NS 
F 17.0 ± 1.8 14.9 ± 3.6 20.3 ± 3.4 19.2 ± 3.4 
long-chain acyl-CoA dehydrogenase, mitochondrial (Acadl) 
M 1076 ± 347* 166 ± 9 204 ± 22 353 ± 72 
0.022 NS 
F 365 ± 23 298 ± 60 302 ± 49 412 ± 91 
adipose triglyceride lipase (Atgl) 
M 1322 ± 297* 429 ± 95 700 ± 48 1453 ± 296 
0.0002 0.0425 
F 701 ± 26 338 ± 95 732 ± 51 1044 ± 149 
hormone-sensitive lipase (Lipe) 
M 631 ± 131 166 ± 38 458 ± 39 674 ± 59 
<0.0001 NS 
F 486 ± 37 218 ± 61 645 ± 84 664 ± 64 
lipoprotein lipase (Lpl) 
M 6299 ± 1305* 1192 ± 279 2283 ± 139 3969 ± 719 
<0.0001 NS 
F 3788 ± 444 1097 ± 80 2783 ± 588 4316 ± 294 
 
The data are the mean ± sem of 6 animals per group, and are expressed as  fkat/g of protein . Statistical significance of the differences between groups was 
established with a 2-way anova; post-hoc Tuckey test: different superscript letters represent P<0.05 differences. 
Supplemental Table 5 Comparison of male-female specific expression of genes in different WAT sites with respect to tissue total RNA.  
 
                (Continues in next page) 
) 
gene sex 
SC ME PG RP all-sites 
P value fmol/mgRNA P fmol/mgRNA P fmol/mgRNA P fmol/mgRNA P 
urea cycle enzymes 
ornithine carbamoyl-transferase M 0.61 ± 0.16 NS 0.020 ± 0.003 NS 0.42 ± 0.05 NS 1.08 ± 0.46 NS NS F 0.27 ± 0.01 0.031 ± 0.007 1.03 ± 0.43 1.24 ± 0.54 
carbamoyl-P synthase 2 M 17.0 ± 2.0 0.0220 6.19 ± 0.27 NS 16.8 ± 2.7 NS 16.4± 1.4 NS NS F 24.0 ± 1.6 5.87 ± 0.54 17.3 ± 2.4 18.4 ± 3.2 
arginino-succinate synthase M 1.94 ± 0.19 NS 0.51 ± 0.04 NS 2.69 ± 0.21 NS 3,67 ± 1.11 NS NS F 1.51 ± 0.18 0.62 ± 0.11 6.31 ± 2.45 4.31 ± 1.51 
arginino-succinate lyase M 13.8 ± 1.2 NS 3.07 ± 0.45 NS 18.5 ± 3.2 NS 11.2 ± 1.1 NS NS F 10.6 ± 0.7 3.65 ± 0.37 15.1 ± 2.0 12.1 ± 1.4 
arginase 1 M 0.56 ± 0.12 NS 0.065 ± 0.018 NS 1.28 ± 0.25 NS 0.50 ± 0.17 NS NS F 0.93 ± 0.28 0.045 ± 0.010 1.60 ± 0.38 1.43 ± 0.61 
Other enzymes of amino acid metabolism 
N-acetyl-glutamate synthase M 0.44 ± 0.095 0.0197 0.11 ± 0.035 NS 0.60 ± 0.18 NS 0.59 ± 0.05 NS NS F 0.12 ± 0.01 0.12 ± 0.037 0.62 ± 0.15 0.72 ± 0.14 
glutamate dehydrogenase 1 M 112 ± 17 NS 38.9 ± 3.6 NS 142 ± 11 NS 155 ± 9 NS NS F 82.9 ± 10 48.4 ± 6.1 157 ± 14 134 ± 16 
glutamine synthetase M 291 ± 74 NS 19.0 ± 2.0 NS 166 ± 9.9 NS 178 ± 5 NS 0.0035 F 109 ± 11 20.0 ± 1.3 139 ± 15 139 ± 19 
glutaminase M 10.5 ± 1.9 NS 1.81 ± 0.22 0.0292 12.0 ± 1.0 NS 20.4 ± 0.8 NS NS F 16.4 ± 2.5 2.62 ± 0.23 10.8± 1.5 17.2 ± 1.6 
AMP deaminase M 25.6 ± 2.3 0.0109 9.05 ± 0.79 NS 16.9± 1.2 NS 19.1 ± 1.2 NS 0.0048 F 16.8 ± 1.4 8.87 ± 0.41 16.0± 0.9 17.8 ± 1.5 
glycine cleavage system M 26.8 ± 4.0 NS 7.08 ± 1.22 NS 32.8 ± 3.2 0.0128 61.3 ± 5.4 NS NS F 18.4 ± 3.0 6.64 ± 0.82 45.7 ± 2.8 65.2 ± 6.4 
alanine transaminase 1 M 91.7 ± 6.3 0.0007 16.5 ± 5.1 NS 150 ± 9 NS 152 ± 10 0.0409 <0.0001 F 45.3 ± 7.1 16.3 ± 3.6 121 ± 15 114 ± 13 
alanine transaminase 2 M 2.67 ± 0.27 0.0104 0.49 ± 0.15 NS 9.90 ± 1.22 0.0034 6.00 ± 0.68 0.0057 <0.0001 F 1.58 ± 0.21 0.56 ± 0.18 3.99 ± 0.46 3.05 ± 0.42 
branched-chain amino acid 
transaminase 1 
M 3.07 ± 0.41 NS 1.62 ± 0.13 NS 4.90 ± 0.25 0.0419 4.04 ± 0.37 0.0087 0.0110 F 3.15 ± 0.59 1.50 ± 0.20 3.82 ± 0.42 2.54 ± 0.25 
branched-chain amino acid 
transaminase 2 
M 36.5 ± 9.8 NS 15.6 ± 3.0 NS 53.5 ± 5.8 NS 74.9 ± 6.0 NS NS F 26.1 ± 3.6 14.6 ± 2.4 66.0 ± 4.7 65.5 ± 4.3 
endothelial nitric oxide synthase M 22.8 ± 4.1 0.0382 2.13 ± 0.28 NS 14.3 ± 1.9 NS 19.7 ± 1.9 0.0102 0.0001 F 11.4 ± 1.5 2.18 ± 0.29 10.4 ± 1.1 12.4 ± 1.0 
Supplemental Table 5 (conclusion) 
 
The data are the mean ± sem of 6 animals per group, and are expressed as fmol of the corresponding mRNA per mg of total RNA. Statistical significance of 
the differences between groups was established with 1- and 2-way anova; NS = P>0.05.  
 
gene sex SC ME PG RP all-sites P value fmol/mgRNA P fmol/mgRNA P fmol/mgRNA P fmol/mgRNA P 
enzymes (and transporters) related with lipogenesis from glucose 
glucose transporter 4 M 36.1 ± 7.9 NS 4.31 ± 1.43 NS 47.3 ± 6.8 NS 56.8 ± 5.6 0.0432 0.0115 F 46.7 ± 9.5 9.34 ± 2.48 69.6± 21.2 101 ± 16 
hexokinase 2 M 3.02 ± 0.18 NS 1.36 ± 0.31 NS 7.07 ± 1.05 0.0365 5.49 ± 0.56 0.0392 0.0001 F 4.45 ± 0.79 2.26 ± 0.46 12.8 ± 2.0 11.5 ± 2.2 
glucose-6P dehydrogenase M 72.7 ± 4.0 NS 13.1 ± 2.3 0.0458 61.9 ± 7.8 0.0192 108 ± 10 0.0198 0.0001 F 63.8 ± 6.7 21.6 ± 2.9 128 ± 20 197 ± 27 
malic enzyme M 344 ± 103 NS 5.15 ± 1.02 0.0485 65.5 ± 14.0 0.0476 147 ± 24 0.0218 0.0018 F 170 ± 43 81.7 ± 29.5 313 ± 95 1022 ± 267 
pyruvate dehydrogenase kinase 2 M 52.7 ± 7.1 0.0450 14.4 ± 2.6 NS 39.3 ± 4.4 NS 56.2 ± 2.9 0.0458 0.0319 F 33.9 ± 2.1 15.6 ± 3.0 38.7 ± 6.3 47.8 ± 2.3 
pyruvate dehydrogenase kinase 4 M 37.2 ± 9.0 0.0164 1.49 ± 0.30 NS 6.49 ± 1.48 NS 18.8 ± 5.2 0.0458 <0.0001 F 5.35 ± 0.72 0.93 ± 0.36 3.89 ± 1.24 5.10 ± 1.09 
citrate: ATP lyase M 33.4 ± 10.6 NS 4.58 ± 1.07 0.0045 48.5 ± 9.8 NS 36.3 ± 8.5 0.0384 0.0016 F 46.0 ± 12.3 28.0 ± 4.9 107 ± 43 290 ± 91 
acetyl-CoA carboxylase M 21.2 ± 3.6 0.0442 3.39 ± 0.51 0.0242 55.0 ± 10.3 NS 112 ± 5 0.0100 <0.0001 F 58.2 ± 13.9 24.1 ± 6.5 120 ± 39 466 ± 88 
fatty acid synthase M 936 ± 234 NS 39.5 ± 14.7 0.0143 496 ± 98 0.0483 789 ± 85 0.0348 0.0018 F 696 ± 134 157 ± 33 1553 ±408 2286 ± 523 
enzymes (and transporters) related with lipolysis and fatty acid oxidation 
carnitine palmitoleoyl transferase 
(liver) 
M 11.7 ± 2.8 0.0491 1.88 ± 0.23 NS 8.90 ± 1.09 0.0137 4.23 ± 0.43 0.001 <0.0001 F 4.55 ± 0.83 1.33 ± 0.18 4.92 ± 0.66 1.68 ± 0.33 
carnitine palmitoleoyl transferase 
(muscle) 
M 3.75 ± 0.91 NS 1.18 ± 0.17 NS 11.7 ± 1.9 NS 19.9 ± 2.1 NS 0.0350 F 3.49 ± 0.60 1.55 ± 0.35 8.67 ± 1.18 15.2 ± 1.2 
long-chain acyl-CoA dehydrogenase M 210 ± 38 0.0214 18.5 ± 1.8 0.0462 168 ± 24 NS 271 ± 26 NS 0.0460 F 86.0 ± 5.5 30.9 ± 4.7 185 ± 37 229 ± 16 
adipose tissue triacylglycerol lipase M 337 ± 73 0.0460 43.2 ± 9.7 NS 667 ± 105 NS 929 ± 61 0.0017 <0.0001 F 145 ± 22 34.3 ± 7.2 477 ± 66 577 ± 56 
hormone-sensitive lipase M 168 ± 37 NS 16.7 ± 3.9 NS 379 ± 48 NS 603 ± 32 NS 0.0131 F 114 ± 8 17.5 ± 4.0 306 ± 31 499 ± 46 
lipoprotein lipase M 1553 ± 68 0.0324 154 ± 41 NS 1796 ± 211 NS 3458 ± 372 0.0440 NS F 1038 ± 177 132 ± 28 2269 ± 263 2275 ± 354 
